Abstract
To explore the role of CDC25B, PED/PEA-15 in the development of esophageal carcinoma and its influence on the prognosis. Fluorescence quantitative real-time PCR and immunohistochemistry methods were used to analyze the expression of CDC25B, PED/PEA-15 in esophageal carcinoma. Moreover, survival analysis was done using the Kaplan-Meier method. In 66 cases of esophageal cancer tissues, the relative content of CDC25B mRNA was 16.22 (13.93-18.90). The positive expression rate of CDC25B protein was 48.5%, significantly higher than normal mucosa tissues (0%) (p<0.01). The relative content of PED/PEA-15 mRNA was 12.47 (10.41-14.93). The positive expression rate of PED/PEA-15 protein was 68.2%, significantly higher than normal mucosa tissues (17.6%) (p<0.01). The CDC25B protein expression was correlated with differentiation grade and depth of invasion (p<0.05). The PED/PEA-15 protein expression was related to differentiation grade, lymph node metastasis, and depth of invasion (p<0.05). Survival analysis showed that the mean survival time of PED/PEA-15-positive expression group was lower compared with the negative expression group (χ(2)=5.549, p=0.018). Analysis of the relationship between CDC25B and PED/PEA-15 suggested that there was ...Continue Reading
References
Jan 17, 1997·Science·M Lopez-IlasacaR Wetzker
Sep 23, 1998·Biochemical Pharmacology·M Lopez-Ilasaca
May 29, 1999·Oncogene·E S WooJ S Lazo
Mar 31, 2000·Progress in Cell Cycle Research·I Nilsson, I Hoffmann
May 24, 2000·Oncogene·N DavezacB Ducommun
Aug 7, 2001·British Journal of Cancer·K NishiokaM Monden
Oct 13, 2001·Cancer Letters·H SasakiY Fujii
Jun 17, 2003·Molecular and Cellular Biology·Alessandra TrenciaFrancesco Beguinot
Mar 9, 2004·Biochemical and Biophysical Research Communications·Sanae UchidaKatsumi Yamashita
Oct 1, 2004·Journal of Cell Science·Arne LindqvistChristina Karlsson Rosenthal
Mar 3, 2005·World Journal of Gastroenterology : WJG·Keijiro SunadaKentaro Sugano
May 3, 2005·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Wataru YasuiHirofumi Nakayama
Feb 27, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E J Nam, Y T Kim
Nov 28, 2008·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Yang ZhangBing-Zhi Yu
Dec 17, 2008·Anti-cancer Agents in Medicinal Chemistry·Bernadette Aressy, Bernard Ducommun
Feb 3, 2009·Biochimica Et Biophysica Acta·Valerie LobjoisBernard Ducommun
Jun 18, 2009·American Journal of Physiology. Endocrinology and Metabolism·Francesca FioryFrancesco Beguinot
Apr 22, 2010·Human Gene Therapy·Ginevra BottaGiuseppe Portella
Sep 4, 2010·Journal of Translational Medicine·Jun DongWan-li Liu
Jul 24, 2012·Biochimica Et Biophysica Acta·Edward C TwomeyYufeng Wei
Apr 23, 2013·Surgery Today·Hiroshi OkumuraShoji Natsugoe
Sep 17, 2013·World Journal of Gastroenterology : WJG·Yuwei Zhang
Nov 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhe ZhangChuize Kong
Jun 14, 2014·Experimental and Therapeutic Medicine·Yongkang YuJianqing Jiang
Citations
May 10, 2017·Cancer Biology & Therapy·Shruti BhargavaKumaravel Somasundaram
Dec 14, 2017·Frontiers in Physiology·Sheng LiXinghuan Wang
Apr 11, 2017·Molecular Medicine Reports·Menglei WangKang Zeng
Oct 27, 2017·Cell Death & Disease·Cristina QuintavalleMatthias Sebastian Matter
Jan 22, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dan XiePengpeng Qu